✦ LIBER ✦

To tap or not to tap: Cerebrospinal fluid biomarkers of Alzheimer's disease

✍ Scribed by John H. Growdon

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 240 KB
Volume: 44
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410440105

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Taps to Alzheimer's patients: A continuo

Taps to Alzheimer's patients: A continuous Japanese study of cerebrospinal fluid biomarkers

✍ Mikio Shoji; Mitsuyasu Kanai; Etsuro Matsubara; Masaki Ikeda; Yasuo Harigaya; Ko 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 1 views

Reply: Cerebrospinal fluid proteomics fo

Reply: Cerebrospinal fluid proteomics for biomarkers of Alzheimer's disease

✍ Kelvin H. Lee; Norman R. Relkin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

Biomarkers of Alzheimer's disease and ex

Biomarkers of Alzheimer's disease and exercise: One step closer to prevention

✍ Yaffe Kristine 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB 👁 1 views

BTN1, a Yeast Gene Corresponding to the

BTN1, a Yeast Gene Corresponding to the Human Gene Responsible for Batten's Disease, is Not Essential for Viability, Mitochondrial Function, or Degradation of Mitochondrial ATP Synthase

✍ PEARCE, DAVID A.; SHERMAN, FRED 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 2 views

The Saccharomyces cerevisiae gene BTN1, encodes a 408 amino acid putative integral membrane protein, which is 39% identical and 59% similar to the human Cln3p, whose mutant forms are responsible for Batten's disease and for a diminished degradation of mitochondrial ATPase synthase subunit c. Disrupt